Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit your nominations for the Fierce CRO Awards
Parkinson's disease
MedTech
Newronika nets CE mark for adaptive DBS in Parkinson's disease
Newronika's AlphaDBS system continuously adjusts its output based on real-time brain signals, instead of the conventional fixed-stimulation doses.
Conor Hale
Mar 26, 2025 10:36am
Hologen AI commits $430M to MeiraGTx Parkinson's gene therapy
Mar 13, 2025 10:51am
Celon's PDE10A inhibitor reduces movements in Parkinson's trial
Mar 5, 2025 6:45am
FDA approves Medtronic’s adaptive DBS implant for Parkinson’s
Feb 24, 2025 10:48am
Biogen axes asset from $7.3B buyout, plus Alzehimer’s prospect
Feb 12, 2025 9:53am
Inhibikase hits pause on Parkinson's program over efficacy
Jan 30, 2025 4:30am
